LIZ IN 2013 DRESSED FOR HER SUGARDADDY: GOING FOR THE GREEN

Bio Viva La Scam™ & Liz Parrish’s Medical Origins & Desires: A True Tale

Liz Parrish did not graduate from college, has no PhD, M.D., RN, LPN, nor ANY MEDICAL BACKGROUND OR DEGREE WHATSOEVER. She once held a hairdresser license which apparently makes her believe she’s eminently qualified to carry out CRISPR and AAV9-Tert gene therapy utilizing Myostatin inhibition with follistatin. She began fundraising for this “project” by joining Sugardaddie.com in order to take advantage of wealthy men to finance her Scam. Read along the following pages in order to hear the initial origin of this pseudoscience, begun in 2013. A 100% true tale which allowed her to fleece one gentleman, distraught over the death of his wife of 34 years from Lymphoma to fly Liz on numerous 1st Class, 5 Star, SugarBaby, Three To Five Day & Weekend Excursions To L.A, Beverly Hills, San Francisco, South Florida and elsewhere until she got what she wanted; the money to incorporate, travel and continue the grift. Sad but interesting you’ll delve into the underbelly of the seedy world of Medical Tourism where Liz has enough hubris to take money from desperate, naive people, virtually anyone Liz can convince she and only she has the key to help them to live forever often utilizing her “SugarBaby” skills to hustle away the money from those who can afford to pay and pay and pay. Allowing her to join the ranks of such non luminaries as Stanislaw Burzinski and Tulio Simoncini along with the well publicized Trust Fund baby of the UK, Aubrey “The Beard” de Grey and Hulda Clark the Nurse who swore to the World that she and only she had the cure for any and all cancers ironically to die from Cancer herself. (Multiple Myeloma). You’ll find the following true, sad but interesting tale revealing and educational regarding the revolting, unpalatable, obnoxiously odious and despicably scandalous world of Liz Parrish, Pseudoscientific Grifter and Shameless SugarBaby.

Testimonials? There Are No “Testimonials.” Just These Fact’s

How can one recite testimonials from non existent “patients” as to date no one but Liz herself has been foolish, mindless, irresponsible, ill-advised, reckless and fatuously foolhardy enough to experiment with CRISPR and AAV9-Tert genetic engineering therapy utilizing Myostatin inhibition and the gene follistatin, attempting to lengthen her Telomeres basically utilizing Telomerase. Don’t Allow The Scientific Terms To Fool You. Many others properly funded have gone down this avenue only to fail. Liz and Bio Viva La Scam© are taking advantage of fancy sounding Scientific Termiminology to do one thing, separate you from your hard earned money. Where? Offshore and online of course insuring they’re not under the ethical auspices of US Law and the FDA where they very well may kill you in the process.

There Are No Services. Bio Viva La Scam™ is A Pseudoscientific Medical Scam.

Liz Parrish is the head of Bio Viva La Scam™ PseudoScience despite having no formal scientific training or degree whatsoever, none. Liz Has No MD, PhD, RN, LPN nor any Degree. Not even a Physical or Online 4 Year College Nor A 2 Year Jr College Degree. Liz Parrish did once hold a tradeschool Degree as a hairdresser but even that’s been revoked. Liz Parrish possess a sharp detailed eye for desperate, naive, wealthy and ill people or their families who will do anything to live longer but more specifically live forever. That along with being physically attractive allows Liz to play the role of SugarBaby, her only actual job. Liz Spots The Marks And Reels Them In From Whom Bio Viva La Scam© Hopes To Hustle The Money.

There are No Coming Events, Just Lies, Lies And More Lies.

Bio Viva La Scam™ has been described as a new, highly controversial medical tourism based scam. Timothy Caulfield, professor in the Faculty of Law and the School of Public Health at the University of Alberta, characterized BioViva as pseudoscience and lacking scientific rigor. Antonio Regalado, reporter for the MIT Technology Review states, “The experiment seems likely to be remembered as a new low in medical quackery.“

Bio Viva La Scam™ Fiji: Promised But Non- Existent

While attempting to locate a Country anywhere in the civiled world in which to get governmental approval to open even a small clinic Liz and BioViva have been turned down by Colombia, Peru, Costa Rica, and particularly Fiji. In early 2016, Sierra Sciences announced that they were working with BioViva to start a new medical tourism-based venture, (Scam) BioViva FIJI, on Fiji and that they will be the first company to use gene therapy to treat biological aging in humans. CEO Liz Parrish explained the reason for setting up in Fiji: “The current regulatory authorities have an outdated model that does not accommodate these new technologies.” Yes, our revoked licensed hairdresser with no Medical training or Degree has determined she knows best in what 1’000’s upon 1,000’s of MD’s & PhD’s, experts in the field disagree. Not surprisingly soon thereafter, In June 2016, government sources in Fiji denied knowledge of the venture and Bill Andrews PhD pulled out and distanced himself from Liz and BioViva quickly with a Press Release.
http://fijisun.com.fj/2016/06/08/authorities-deny-anti-ageing-clinic-being-set-up-here/

Bio Viva La Scam™ Genetic Engineering In Institute For Ethics In Emerging Technology

Much is being made recently about telomerase as the cure for what ails you. Activating telomerase is touted by Bioviva as a supposed cure for Alzheimer’s disease. (In fact, the article referenced advances an hypothesis.)
A PR announcement that appears related has appeared.
Others have advanced telomeres as the key to aging for many years. Mice treated with telomerase gene therapy reversed many aspects of age related degeneration. Mice with telomerase expression that also had over-expression of cancer resistance genes lived 25% longer lives. Telomerase deficient mice also had a similar result when telomerase was restored. This appears to be a robust result in mouse model.
Telomerase gene therapy is very different from the drugs that have been pursued by Sierra Sciences and others. If you have a problem with a drug, you can stop taking it. It’s difficult or impossible to do that with gene therapy.
Some of the results for TERT gene expression appear quite desirable. “The beneficial effects of telomerase are particularly notable in epithelial tissues, which show an improved fitness and a more efficient epithelial barrier function at old ages, resulting in decreased aging-associated inflammatory processes.”
However, not all evidence on telomerase is good and some claims don’t stand up to examination. Telomerase is activated in most cancers (over 90%) which is critical to allow those cells to become immortal. That is why, to get unusual longevity, researchers also enhanced cancer resistance. “Tert expression can significantly delay aging in mice, although this requires counteracting the protumorigenic effects of telomerase by increasing tumor suppression.”
Evolution works with tradeoffs. Large, long-lived mammals are extremely conservative with the activation of telomerase in somatic cells. Some very long-lived species like elephants, over-express anti-tumor genes naturally, which helps them avoid cancer. But mouse somatic fibroblasts do have active telomerase. Mice live a couple of years, and to a great degree, cancer in animals is a function of probability. The number of cells in a mouse is less than the number of cells in a human hand. The more cells there are, the higher the odds should be of changes leading to cancer in one of those cells. And the longer an animal’s life span, the more time it has for something to go wrong.
We know, for instance, that radiation late in human life has little chance of triggering cancer – even very large doses. When we look for effects of small radiation doses, we look for them appearing after irradiation in childhood, and even then, those effects are extremely weak. A small, short-lived animal has less reason to minimize telomerase to control cancer.
In human skin, approximately 25% of adult cells exposed to sunlight show pre-cancerous changes. Adding a gene critical to transforming those cells into cancer isn’t wise. I have read the opinion on a blog that telomerase expression will defeat cancer, but there is no evidence I am aware of this is true. If there is evidence for it in science, I would like to know about it.
In Alzheimer’s disease, a mouse model showed improvement when telomerase is down regulated. “…telomere shortening, despite impairing adult neurogenesis and maintenance of post-mitotic neurons, can slow down the progression of amyloid plaque pathology in Alzheimer’s disease…” This is the opposite of the idea that Dr. Fossel wrote suggesting telomerase activation could treat Alzheimer’s. This study is a mouse model of Alzheimer’s, and there may be differences from human, but it should not be dismissed without evidence.
How could it be that Alzheimer’s could be made worse? Well, in this mouse model of Alzheimer’s, whatever triggers the amyloid plaque is pretty clearly independent of telomerase. So turning telomerase on once plaques develop only makes those cells better at making plaques. Telomerase is only one clock in the genome. There are many of them and we are just beginning to catalog those clocks and how they work.
The mice in the second telomerase restoration study did not live longer than normal mice. And while the first telomerase study above claimed no increase in cancer rate, that study’s numbers (23 TERT treated mice) were not remotely high enough to make that claim. If cancer had been seen with such small numbers, it would mean that this therapy was astoundingly dangerous. In human populations, a cancer increase from 15 in 100,000 to 20 in 100,000 is meaningful.
In this first study, the increase in life span was 20% for mice 1 year old at injection, and 13% for mice 2 years old at injection. That’s a significant increase in life span, but equaled by quite a few other therapies as we can see in the chart. When you look at this chart you can see several things. First, there are a number of drugs that extend life-span. And second, that in different studies of the same drug at the same dose there is wide range of results. What this tells us is that there are many variables that affect life-span, and those other variables are changing the drug results. For instance, rapamycin can extend life by 7.5% or 22%.
Given this context, marketing unofficial, tiny, clinical trials to the public with overblown unsupported claims is not ethical. Biology is very complex, and amateurs picking up blog posts or speculations off the internet are not helpful to the field. I understand the impatience. I had a career in software, and worked for multiple startups prior to my grad school work on gene therapy and vaccines. Investors in the Silicon Valley who are used to software startups want the impossible, and seem to prefer it.
Biopharma is very different from software. Biology is slow because one frequently finds apparently paradoxical results, and the systems are slow to tell you. Usually, when you affect one thing, you affect quite a few others as well. When you do find out that you have made a mistake, it’s a very big deal when it’s a human involved.
So far, there have been 7 patients killed by gene therapy clinical trials And What Parrish & BioViva Are Doing Are Not Clinical Trials But Attempting To Ride The Backs Of The Rigorous Scientific Method Which Itself Has Already Killed People In An Attempt To Get Around US Laws & The FDA In A Scam To Make Money. Attribution For This Article Which Originally Appeared In The Institute For Ethics In Emerging Technology’s Belongs To Brian Hanley PhD and CEO Of Butterfly Sciences. Brian Hanley is the founder of Butterfly Sciences, a company developing gene therapies for aging. Unlike Liz Parrish He has a range of papers in biosciences, economics, policy and terrorism, in addition to a recent text on radiation treatment. Also unlike Liz Parrish He obtained his PhD in microbiology with honors from UC Davis, has a bachelors degree in computer science, is a multiple entrepreneur and guest lectured for years to the MBA program at Santa Clara University.